Welcome Eleni Flanagan!

Welcome Eleni Flanagan!

Posted by  | Nursing Matters

The Department of Medical Nursing is pleased to announce that effective March 6, 2016, Eleni Flanagan, MSN, MBA, RN-BC, will be appointed the Assistant Director of Nursing. In her new role, Eleni will oversee in-patient and procedural nursing operations for the department. Eleni is an exceptional leader with over 11 years of nursing leadership and operational experience. In fact, over the last 20 years, she has(...)

Read More

Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease

Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease

Posted by  | Article of the Week

ARTICLE: Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease AUTHORS: Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME JOURNAL: JAMA Intern Med. 2016 Feb 1;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193 Abstract IMPORTANCE: Proton pump inhibitors (PPIs) are among the most commonly used drugs worldwide and have been linked to acute interstitial nephritis. Less is known about the association between PPI(...)

Read More

Donowitz Receives Distinguished Achievement Award

Donowitz Receives Distinguished Achievement Award

Posted by  | Congratulations

Mark Donowitz, professor in the Division of Gastroenterology, will receive the Distinguished Achievement Award in Basic Science from the American Gastroenterological Association at an awards ceremony in May. Established in 1968, the award recognizes senior investigators who have made major accomplishments in basic science research that have significantly advanced the science and/or practice of gastroenterology.(...)

Read More

Welcome to BCU update!

Welcome to BCU update!

Posted by  | Patient Care

This is where we will keep you updated on the Johns Hopkins Hospital Biocontainment Unit news, events and activities. The unit officially opened on May 20, 2015, and has activated on three occasions: once for a patient in isolation and twice to run laboratory tests on potential patients. Shortly after opening, the Johns Hopkins Hospital(...)

Read More

Bleary-eyed doctors may be better for patients

Bleary-eyed doctors may be better for patients

Posted by  | Education, Patient Care

Let's say your mother requires a colon resection due to a small cancer and has to be admitted to one of two hospitals in town. Both are well-respected teaching hospitals full of surgery residents - young doctors who have recently completed medical school and are training under the supervision of experienced surgeons. In both hospitals,(...)

Read More

Bumpus Receives Presidential Early Career Award for Scientists and Engineers

Bumpus Receives Presidential Early Career Award for Scientists and Engineers

Posted by  | Congratulations

The Presidential Early Career Awards for Scientists and Engineers is the highest honor bestowed by the United States Government on science and engineering professionals in the early stages of their independent research careers. Namandje Bumpus, associate professor in the Division of Clinical Pharmacology, is one of 105 researchers who will be honored by President Obama(...)

Read More

Partnering with Patients in Decision-Making: Continuing the Conversation at Johns Hopkins

Posted by  | Leadership, Patient Care

Partnering with Patients in Decision-Making: Continuing the Conversation at Johns Hopkins will take place on June 1, 2016, from 8 a.m. to 5 p.m., in the Owens Auditorium in the Cancer Research Building. Open to all, this meeting will feature discussions of clinical, educational and research approaches to decision making in the Johns Hopkins Medicine(...)

Read More

GBR II – What’s next?

GBR II – What’s next?

Posted by  | Administration, Patient Care

The new Global Budget Revenue (GBR) agreements seem to be working. Initial statewide data show hospital volume is declining and quality is improving. We are now entering year three of a five-year demonstration project with the Centers for Medicare & Medicaid Services (CMS) as part of the waiver modernization program.  So what’s next? One of(...)

Read More

HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial

HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial

Posted by  | Article of the Week

ARTICLE: HIV Salvage Therapy Does Not Require Nucleoside Reverse Transcriptase Inhibitors: A Randomized, Controlled Trial AUTHORS: Karen T. Tashima, Laura M. Smeaton, Carl J. Fichtenbaum, Adriana Andrade, Joseph J. Eron, Rajesh T. Gandhi, Victoria A. Johnson, Karin L. Klingman, Justin Ritz, Sally Hodder, Jorge L. Santana, Timothy Wilkin and Richard H. Haubrich, on behalf of the A5241(...)

Read More